Trial Profile
The Effect of Solifenacin on Post Void Dribbling in Women: A Randomized Controlled Multicenter Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Urinary incontinence
- Focus Therapeutic Use
- 09 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Nov 2011 New trial record